Zoetis, Inc. Investors: Company Investigated by the Portnoy Law Firm
April 12, 2024 15:06 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 12, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Zoetis, Inc. (“Zoetis”)...
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 11, 2024 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001
April 03, 2024 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Fox Factory Holding Corp. (FOXF)
February 23, 2024 13:38 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against Fox Factory Holding Corp.
Robbins LLP Urges EAF Shareholders to Seek Legal Counsel Prior to the March 25 Lead Plaintiff Deadline
February 12, 2024 13:22 ET
|
Robbins LLP
GrafTech International Ltd. (EAF) Misled Investors Regarding the Environmental Impact of its Business Operations
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001
January 02, 2024 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Jan. 02, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Announces Closing of a Private Placement
December 18, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Announces Extension of Warrants
November 30, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
US Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives
November 15, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
DMTK SHAREHOLDERS: Contact Robbins LLP for Information Regarding the Class Action Against DermTech, Inc.
October 30, 2023 18:19 ET
|
Robbins LLP
DermTech, Inc. (DMTK) Misled Investors Regarding its Business Prospects